Nancie M. Archin

Nancie M. Archin, PhD, is an Assistant Professor at the University of North Carolina at Chapel Hill School of Medicine, affiliated with the Division of Infectious Diseases and the Institute for Global Health and Infectious Diseases. Her research focuses on HIV latency and cure strategies, particularly in women, using molecular biology and biochemical approaches to identify sex-specific factors and develop clinical applications for reservoir clearance.

• Education: Stony Brook University (Undergraduate), UT Health Science Center (Graduate), UT Southwestern Medical Center (Postdoctoral), and UNC Chapel Hill (Postdoctoral training).

Research Areas: Dr. Archin investigates HIV persistence in women, latency reversal agents, immune-mediated clearance, and clinical translation of antiviral strategies. Her work bridges molecular mechanisms with population-specific health disparities.

Scientific Awards:

• Diversity in Science and Excellence award (2024), International Society for Antiviral Research

Publications: Recent studies highlight CRISPR screening for latency regulators, HDAC inhibitor effects on reservoir formation, and non-canonical NF-κB signaling in latency reversal. Articles span 2014–2025, reflecting sustained contributions to HIV cure research.

Lab: The Archin Lab develops molecular tools to disrupt HIV latency and translate findings into clinical trials, emphasizing underrepresented populations in virology.